119-HRES-805 Investigative Journalist Impact Analysis

Summary

What the measure does: H.Res. 805 recognizes October 2025 as “American Pharmacists Month.” As a simple House resolution, it expresses the sense of the House only; it is not presented to the President, does not become law, and typically has no budgetary or regulatory effect. Status: introduced and referred to the House Committee on Energy and Commerce on October 14, 2025. [1]U.S. House of Representatives — Bills & Resolutions | The Legislative Process[2]Congress.gov (Library of Congress) — H.Res.805 — 119th Congress (2025–2026)

Economic Effects

Direct fiscal effects are de minimis; any economic signals are indirect and reputational.

• No direct federal spending or regulatory mandates. Simple House resolutions do not carry the force of law or appropriate funds; Congress.gov lists no CBO score for H.Res. 805. [1]U.S. House of Representatives — Bills & Resolutions | The Legislative Process[2]Congress.gov (Library of Congress) — H.Res.805 — 119th Congress (2025–2026)
• Sector context: pharmacists held about 335,100 U.S. jobs in 2024; pharmacy technicians about 490,400, with both occupations projected to grow ~5–6% through 2034. Recognition events may marginally raise local traffic but evidence of macroeconomic effects from commemorative resolutions is lacking. [3]U.S. Bureau of Labor Statistics — Pharmacists — Occupational Outlook Handbook[4]U.S. Bureau of Labor Statistics — Pharmacy Technicians — Occupational Outlook H…
• Operating pressures persist irrespective of the resolution: retail pharmacy closures accelerated in 2018–2021 and nearly 30% of outlets operating during 2010–2020 had closed by 2021, with heightened risk in Black and Latino neighborhoods. Closures affect revenues, employment, and local service availability. [5]USC Schaeffer Center — More US pharmacies closed than opened in 2018–21; indepe…[6]Associated Press — Nearly 30% of US drugstores closed in one decade, study shows
• Market dynamics: the FTC’s interim staff work describes PBM practices (markups, steering to affiliated pharmacies, spread pricing) that can shape pharmacy margins and viability—issues not addressed by symbolic recognition. [7]Federal Trade Commission — FTC Releases Second Interim Staff Report on Prescrip…

Social Effects

Potential social impacts stem from awareness and professional recognition; direct service delivery remains governed by existing law and payer rules.

• Accessibility baseline: during the COVID‑19 response, CDC built vaccination strategy around pharmacies, noting that most Americans live within five miles of a pharmacy—supporting the idea that pharmacies are ubiquitous touchpoints even if the resolution itself does not expand services. [8]Centers for Disease Control and Prevention — The Federal Retail Pharmacy Progra…
• Service utilization: in the 2023–24 respiratory virus season, pharmacies/drug stores were the most common adult vaccination setting (approx. 48% flu; 71.5% updated COVID‑19; 81.7% RSV), underscoring their current role in preventive care. [9]Centers for Disease Control and Prevention — National and state-specific estima…
• Clinical outcomes evidence: pharmacist‑led interventions are associated with improved medication adherence and better cardiometabolic risk control in multiple meta‑analyses (e.g., improved HbA1c and blood pressure), but these benefits materialize only when such services are implemented and reimbursed—none of which is altered by a commemorative resolution. [10]PubMed / Elsevier — Pharmacy‑led interventions to improve medication adherence…[11]PubMed — Pharmacist‑Led Self‑management Interventions to Improve Diabetes Outco…[12]NIH / NLM (NCBI Bookshelf) — Impact of pharmacist care in management of cardiov…
• Equity context: widespread retail pharmacy closures since 2010 disproportionately impact Black and Latino neighborhoods, compounding access barriers; a symbolic month of recognition does not counteract these structural patterns absent further policy. [5]USC Schaeffer Center — More US pharmacies closed than opened in 2018–21; indepe…[6]Associated Press — Nearly 30% of US drugstores closed in one decade, study shows
• Workforce well‑being: surveys and professional bodies highlight staffing shortages and burnout in pharmacy settings; recognition may aid morale but does not resolve workload or reimbursement drivers. [13]PubMed / American Society of Health-System Pharmacists — ASHP National Survey o…[14]American Association of Colleges of Pharmacy — National Pharmacist Workforce St…

Environmental Effects

No direct environmental provisions are included; any effects are incidental via awareness of medication disposal.

• Medication disposal: DEA’s National Prescription Drug Take Back Day collected about 620,321 lbs (310 tons) of medications in April 2025; heightened public messaging during a recognition month could bolster participation, but the resolution imposes no programmatic requirements. [15]Drug Enforcement Administration — DEA National Prescription Drug Take Back Day…
• Environmental risk context: EPA identifies pharmaceuticals and personal‑care products as “contaminants of emerging concern” affecting aquatic life, reinforcing the value of proper disposal. [16]U.S. Environmental Protection Agency — Contaminants of Emerging Concern includi…
• Disposal guidance: FDA recommends flushing only specific high‑risk medicines when take‑back options are unavailable and has assessed listed products as posing negligible environmental risk relative to poisoning risk—again, unchanged by the resolution. [17]U.S. Food and Drug Administration — Drug Disposal: FDA’s Flush List for Certain…

Temporal Analysis

1. Immediate (Oct 2025): Symbolic recognition; potential uptick in media coverage and professional events. No statutory or budgetary changes; committee referral occurred on October 14, 2025. [1]U.S. House of Representatives — Bills & Resolutions | The Legislative Process[2]Congress.gov (Library of Congress) — H.Res.805 — 119th Congress (2025–2026)
2. Near term (0–12 months): Indirect effects hinge on stakeholder initiatives (e.g., health‑system campaigns, take‑back drives, immunization outreach). Any measurable outcomes would be attributable to those programs—not to the resolution per se. (No citation—analytic framing.)
3. Longer term (>1 year): Sector trajectories are likely dominated by reimbursement policies, PBM market conduct, workforce capacity, and outlet consolidation/closures documented in recent analyses. [7]Federal Trade Commission — FTC Releases Second Interim Staff Report on Prescrip…[5]USC Schaeffer Center — More US pharmacies closed than opened in 2018–21; indepe…

Unintended Consequences

Risks are not from the text itself but from how symbolism can interact with ongoing market and policy dynamics.

• Policy substitution risk: celebrations can be cited as evidence of support while leaving reimbursement, PBM practices, and access disparities unaddressed. FTC staff’s interim findings point to persistent PBM incentives that can disadvantage unaffiliated pharmacies. [7]Federal Trade Commission — FTC Releases Second Interim Staff Report on Prescrip…
• Equity optics: awareness campaigns may be most visible in well‑resourced communities, potentially masking continuing pharmacy closures that disproportionately affect Black and Latino neighborhoods. [5]USC Schaeffer Center — More US pharmacies closed than opened in 2018–21; indepe…
• Workforce fatigue: public‑facing events during a recognition month could add duties to already strained staff unless paired with staffing or scheduling adjustments documented as lacking in many sites. [13]PubMed / American Society of Health-System Pharmacists — ASHP National Survey o…

Assessment

Overall stance: Neutral. H.Res. 805 is a symbolic recognition with negligible direct economic, social, or environmental effects. Any benefits will depend on external initiatives (e.g., immunization campaigns, safe‑disposal drives, workforce actions) rather than the resolution itself; meanwhile, structural challenges—PBM practices, outlet closures, workforce strain—remain the decisive drivers of real‑world impacts. [1]U.S. House of Representatives — Bills & Resolutions | The Legislative Process[7]Federal Trade Commission — FTC Releases Second Interim Staff Report on Prescrip…[5]USC Schaeffer Center — More US pharmacies closed than opened in 2018–21; indepe…[13]PubMed / American Society of Health-System Pharmacists — ASHP National Survey o…

Sourcing

Key references underpinning this analysis.

• Measure and process: Congress.gov bill page; House explainer on simple resolutions. [2]Congress.gov (Library of Congress) — H.Res.805 — 119th Congress (2025–2026)[1]U.S. House of Representatives — Bills & Resolutions | The Legislative Process
• Workforce and labor market: BLS Occupational Outlook (pharmacists; pharmacy technicians). [3]U.S. Bureau of Labor Statistics — Pharmacists — Occupational Outlook Handbook[4]U.S. Bureau of Labor Statistics — Pharmacy Technicians — Occupational Outlook H…
• Access and vaccination setting data: CDC Federal Retail Pharmacy Program overview (archived); CDC vaccination setting estimates, 2023–24. [8]Centers for Disease Control and Prevention — The Federal Retail Pharmacy Progra…[9]Centers for Disease Control and Prevention — National and state-specific estima…
• Clinical effectiveness evidence: systematic reviews/meta‑analyses on pharmacist‑led care. [10]PubMed / Elsevier — Pharmacy‑led interventions to improve medication adherence…[11]PubMed — Pharmacist‑Led Self‑management Interventions to Improve Diabetes Outco…[12]NIH / NLM (NCBI Bookshelf) — Impact of pharmacist care in management of cardiov…
• Market pressures and closures: USC/Health Affairs research and national reporting. [5]USC Schaeffer Center — More US pharmacies closed than opened in 2018–21; indepe…[6]Associated Press — Nearly 30% of US drugstores closed in one decade, study shows
• PBM conduct: FTC interim staff report (2025). [7]Federal Trade Commission — FTC Releases Second Interim Staff Report on Prescrip…
• Environmental/disposal: EPA CEC overview; DEA Take Back Day results (April 2025); FDA flush‑list guidance. [16]U.S. Environmental Protection Agency — Contaminants of Emerging Concern includi…[15]Drug Enforcement Administration — DEA National Prescription Drug Take Back Day…[17]U.S. Food and Drug Administration — Drug Disposal: FDA’s Flush List for Certain…